Abstract
Flow cytometric DNA content analysis provides a rapid and reliable analysis of DNA ploidy and the proliferative fraction of tumor specimens. Both archival and fresh specimens are suitable for this technique. This information can be used in conjunction with traditional prognostic factors in the biological assessment of certain carcinomas. Among these tumors are early stages of breast, colon, lung, and bladder carcinomas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barlogie, B., Göhde, W., Johnston, D. A., et al. (1978) Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res. 38, 3333–3339.
Barlogie, B., Drewinko, B., Schumann, J., et al. (1980) Cellular DNA content as a marker of neoplasia in man. Am. J. Medicine 69, 195–203.
Hiddemann, W., Schumann, J., Andreeff, M., et al. (1984) Convention on nomenclature for DNA cytometry. Cytometry 5, 445–446.
Merkel, D. E., Dressler, L. G., and McGuire, W. L. (1987) Flow cytometry, cellular DNA content, and prognosis in human malignancy. J. Clin. Oncol. 5, 1690–1703.
Koss, L. G, Czerniak, B., Herz, F., and Wersto, R. P. (1989) Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum. Pathol. 20, 528–548.
Seckinger, D., Sugarbaker, E., and Frankfurt, O. (1989) DNA content in human cancer. Arch. Pathol. Lab. Med. 113, 619–626.
Shapiro, H. M. (1989) Flow cytometry of DNA content and other indicators of proliferative activity. Arch. Pathol. Lab. Med. 113, 591–597.
Vohn, M. (1989) Prognostic implications of DNA aneuploidy and proliferative activity in solid human tumors. Tumor Diagn. Ther. 10, 229–232.
Raber, M. N. and Barlogie, B. (1990) DNA flow cytometry of human solid tumors, in Flow Cytometry and Cell Sorting, 2nd edit. (Melamed, M. R., Lindmo, T., and Mendelsohn, M. L., eds.), Wiley-Liss, New York, pp. 745–754.
Williams, N. N. and Daly, J. M. (1990) Flow cytometry and prognostic implications in patients with solid tumors. Surgery 171, 257–266.
Wersto, R. P., Liblit, R. L., and Koss, L. G (1991) Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms. Hum. Pathol. 22, 1085–1098.
Camplejohn, R. S. (1992) Critical summaries, flow cytometry. J. Pathol. 166, 323–326.
El-Naggar, A. K. (1992) Clinical relevance of the flow cytometric analysis in cancer. Cancer J. 5, 321–327.
Sasaki, K. and Murakami, T. (1992) Clinical application of flow cytometry for DNA analysis of solid tumors. Acta Pathol. Jpn. 42, 1–14.
Barlogie, B., McLaughlin, P., and Alexanian, R. (1987) Characterization of hematolgoic malignancies by flow cytometric. Anal. Quant. Cytol. Histol. 9, 147–155.
Andreeff, M. (1990) Flow cytometry of leukemia, in Flow Cytometry and Cell Sorting, 2nd edit. (Melamed, M. R., Lindmo, T., and Mendelsohn, M. L., eds.), Wiley-Liss, New York, pp. 697–724.
Andreeff, M. (1990) Flow cytometry of lymphoma, in Flow Cytometry and Cell Sorting, 2nd edit. (Melamed, M. R., Lindmo, T., and Mendelsohn, M. L., eds.), Wiley-Liss, New York, pp. 725–743.
Hedley, D. W., Shankey T. V., and Wheeless, L. L. (1993) DNA cytometry consensus conference. Cytometry 14, 471.
Shankey, T. V., Rabinovitch, P. S., Bagwell, B., et al. (1993) Guidelines for the implementation of clinical DNA cytometry. Cytometry 14, 472–477.
Wheeless, L. L., Badalament, R. A., de Vere White, R. W., Fradet, Y., and Tribukait, B. (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14, 482–485.
Hedley, D. W, Cark, G. M., Cornelisse, C. J., Killander, D., Kute, T., and Merkel, D. (1993) Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14, 482–485.
Bauer, K. D., Bagwell, C. B., Giaretti, W., et al. (1993) Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14, 486–491.
Duque, R. E., Andreeff, M., Braylan, R. C, Diamond, L. W., and Peiper, S. C. (1993) Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry 14, 492–496.
Shankey, T. V., Kallioniemi, O.-P., Koslowski, J. M., et al. (1993) Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14, 497–500.
Kute, T. E., Gregory, B., Galleshaw, J., Hopkins, M., Buss, D., and Case, D. (1988) How reproducible are flow cytometry data from paraffin-embedded blocks? Cytometry 9, 494–498.
Hedley, D. W (1989) Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 10, 229–241.
Joensuu, H. and Kallioniemi, O.-P (1989) Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry 10, 711–717.
McLemore, D. D., El-Naggar, A., Stephens, L. C, and Jardine, J. H. (1990) Modified methodology to improve flow cytometric DNA histograms from paraffin-embedded material. Stain. Technol. 65, 279–291.
Arber, D. A. and Speights, V. O. (1991) Aneuploidy in benign seminal vesicle epithelium: an example of the paradox of ploidy studies. Mod. Pathol. 4, 687–689.
Alderision, M., Cenci, M., Valli, C, et al. (1998) Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder. Anticancer Res. 18, 4225–4230.
Gregoire, M., Fradet, Y, Meyer, F, et al. (1997) Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during follow-up for bladder tumors. J. Urol. 157, 660–1664.
Granfors, T., Duchek, M., Tomic, R., Roos, G, and Ljungberg, B. (1996) Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy. Scand. J. Urol. Nephrol. 30, 281–285.
Ross, J. S., Sheehan, C. E., Ambros, R. A., et al. (1999) Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer. Am. J. Surg. Pathol. 161, 296–301.
Amling, C. L., Lerner, S. E., Martin, S. K., Slezak, J. M., Blute, M. L., and Zincke, H. (1999) Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J. Urol. 161, 857–862.
Astrom, L., Weimarck, A., Aldenborg, F., et al. (1998) S-phase fraction related to prognosis in localized prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1. Int. J. Cancer 79, 553–559.
Witzig, T. E., Ingle, N. K., Schaid, D. J., et al. (1993) DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials. J. Clin. Oncol. 11, 351–359.
Romero, H., Schneider, J., Burgos, J., Bilbao, J., and Rodriguez-Escudero, F. J. (1996) S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers. Breast Cancer Res. Treat. 38, 265–275.
Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on may 17, 1996 by the American Society of Clinical Oncology [see comments]. (1996) J. Clin. Oncol. 14, 2843–2877.
Wenger, C. R. and Clark, G. M. (1998) S-phase fraction and breast cancer—a decade of experience. Breast Cancer Res. Treat. 51, 255–265.
Giella, J. G., Ring, K., Olsson, C. A., Karp, F. S., and Benson, M. C. (1992) The predictive value of flow cytometry and urinary cytology in the follow-up of patients with transitional cell carcinoma of the bladder. J. Urol. 148, 293–296.
Wheeless, L. L., Badalament, R. A., de Vere White, R. W., Fradet, Y., and Tribukait, B. (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry 14, 478–481.
Reles, A. E., Gee, G, Schellschmidt, I., et al. (1998) Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry [see also comments]. Gynecol. Oncol. 71, 3–13.
Zanetta, G, Keeney, G L., Cha, S. S., Wieand, H. S., Katzmann, J. A., and Podratz, K. C. (1996) DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation. Gynecol. Oncol. 74, 208–212.
Muguerza, J. M., Diez, M., Torres, A. J., et al. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: rationale of sequential processing of frozen and paraffin-embedded tissue. World J. Surg. 21, 323–329.
Roberts, H. L., Komaki, R., Allen, P., and El-Naggar, A. K. (1998) Prognostic significance of DNA content in stage I adenocarcinoma of the lung. Int. J. Rad. Oncol. Biol. Phys. 41, 573–578.
Karlsson, M., Boeryd, B., Carstensen, J., et al. (1996) Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J. Cancer 32A, 357–362.
Lanza, G., Gafa, R., Santini, A., et al. (1998) Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Cancer 82, 49–59.
Nervi, C, Badaracco, G., Maisto, A., Mauro, F., Tirindelli-Danesi, D., and Starace, G (1982) Cytometric evidence of cytogenetic and proliferative heterogeneity in human solid tumors. Cytometry 2, 303–308.
Kallioniemi, O.-P. (1988) Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 9, 164–169.
van der Linden, J. C, Herman, C. J., Boenders, J. G, van de Sandt, M. M., and Lindeman, J. (1992) Flow cytometric DNA content of fresh tumor specimens using keratin-antibody as second stain for two parameter analysis. Cytometry 13, 163–168.
Frei, J. V. and Martinez, V. J. (1993) DNA flow cytometry of fresh and paraffin-embedded tissue using cytokeratin staining. Mod. Pathol. 6, 599–605.
Park, C. H. and Kimler, B. F (1994) Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by “cross-gating.” Anticancer Res. 14, 29–36.
Kenyon, N. S., Schmitting, R. J., Siiman, O., Burshteyn, A., and Bolton, W. E. (1994) Enhanced assessment of DNA/proliferative index by depletion of tumor infiltrating leukocytes prior to monoclonal antibody gated analysis of tumor cell DNA. Cytometry 16, 175–183.
Zarbo, R. J., Brown, R. D., Linden, M. D., Torres, F X., Nakhleh, R. E., and Schultz, D. S. (1994) Rapid (one-shot) staining method for two-color multipara-metric DNA flow cytometric analysis of carcinoma using staining for cytokeratin and leukocyte common antigen. Am. J. Clin. Pathol. 101, 638–642.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
El-Naggar, A.K., Vielh, P. (2004). Solid Tumor DNA Content Analysis. In: Hawley, T.S., Hawley, R.G. (eds) Flow Cytometry Protocols. Methods in Molecular Biology™, vol 263. Humana Press. https://doi.org/10.1385/1-59259-773-4:355
Download citation
DOI: https://doi.org/10.1385/1-59259-773-4:355
Publisher Name: Humana Press
Print ISBN: 978-1-58829-234-6
Online ISBN: 978-1-59259-773-4
eBook Packages: Springer Protocols